has been cited by the following article(s):
|
[1]
|
Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior
Pharmacology Biochemistry and Behavior,
2025
DOI:10.1016/j.pbb.2025.173996
|
|
|
|
|
[2]
|
Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis
Neuropsychiatric Disease and Treatment,
2023
DOI:10.2147/NDT.S408794
|
|
|
|
|
[3]
|
New Rapid-acting Antidepressants
Contemporary Clinical Neuroscience,
2021
DOI:10.1007/978-3-030-79790-4_8
|
|
|
|
|
[4]
|
Rapid Acting Antidepressants
Advances in Pharmacology,
2020
DOI:10.1016/bs.apha.2020.04.002
|
|
|
|